Close
Close
Treatment Database
N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt
Trade Name not avaiable
Orphan Indication Congenital adrenal hyperplasia
USA Market Approval
USA Designation Date 17-08-2017
Sponsor Millendo Therapeutics, Inc.
301 North Main Street, Suite 100
Ann Arbor, Michigan, 48104
More about Congenital adrenal hyperplasia
Free Newsletter
Videos